跳至主要内容
临床试验/IRCT201410251556N67
IRCT201410251556N67已完成未知

Acetaminophen as an adjuvant in the treatment of chronic schizophrenia: a double blind and randomised trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria:1-Diagnosis of Schizophrenia based on DSM-5 criteria;2- Minimum Score of 60 on Positive and Negative Scale 3- Age between 18-55; 4- chronic Schizophrenia- duration of the disorder more than 2 years; ; 6-Minimum score of 20 in negative suscale

排除标准

  • 1-any other major mental disorder based on DSM-5; 2-Any serious medical or neurological problem; 3- IQ less than 70;4- Substance dependence during the last 6 months(except for nicotine and caffeine) 5-receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month; ;6-receiving ECT during the last 14 days,7-hepatic and renal disease; 7- history of abnormal bleeding

研究者

相似试验

Acetaminophen in the treatment of schizophrenia | 临床试验